AWTTC recognised at Antibiotic Guardian Awards 2025

30 June 2025

The Antibiotic Guardian Awards 2025, part of the ongoing Antibiotic Guardian campaign led by the UK Health Security Agency, celebrated outstanding contributions from across the UK and around the world in tackling antimicrobial resistance (AMR). The event provided a platform to share learning and showcase innovative efforts aimed at reducing unnecessary antibiotic use. AWTTC was proud to be shortlisted for two projects, reflecting our commitment to improving antibiotic stewardship in Wales.

In the Prescribing and Stewardship category, Rachel Jonas presented a poster highlighting the development of All Wales guidance for penicillin allergy de-labelling in adults in secondary care. The guidance aims to support best practice in identifying and removing inaccurate penicillin allergy labels in adults who have not experienced a true hypersensitivity reaction.

In the Innovation and Technology category, Shaila Ahmed led a project focused on adherence to appropriate antimicrobial course durations. The team developed national course duration messages using ScriptSwitch, a prescribing decision support tool used in primary care. These messages are designed to reduce unnecessary antibacterial exposure and help combat AMR by promoting the shortest effective courses of treatment.

Developed in collaboration with NHS Wales colleagues, both submissions highlight AWTTC’s ongoing contribution to quality improvement across the healthcare system. The event was also a proud occasion for the wider Welsh team, with numerous colleagues from across Wales acknowledged for their impactful work. It provided a valuable opportunity to engage with the newly appointed Chief Medical Officer for Wales, Professor Isabel Oliver.

The event offered a valuable platform for learning, sharing best practice, and connecting with others committed to appropriate antibiotic use. AWTTC remains committed to supporting antimicrobial stewardship through guidance, evidence, and collaboration, ensuring continued progress in the fight against antimicrobial resistance.